Highlights
NASDAQ: BLUE       Bluebird Bio
Last Price Today's Change   Day's Range   Trading Volume
128.75   +0.90 (0.70%)  127.00 - 130.50  480,800

Overview

 
Avg Volume (4 weeks):1,174,731
4 Weeks Range:102.30 - 136.85
4 Weeks Price Volatility (%):
76.56%
52 Weeks Range:37.05 - 136.85
52 Weeks Price Volatility (%):
91.88%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

bluebird bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene therapy and gene editing capabilities, it has built an integrated product platform with various applications in these areas. The Company's clinical programs in severe genetic diseases include its LentiGlobin product candidate to treat transfusion-dependent b-thalassemia and to treat severe sickle cell disease (SCD) and its Lenti-D product candidate to treat cerebral adrenoleukodystrophy (CALD). Its programs in oncology focuses on developing T cell-based immunotherapies, including chimeric antigen receptor (CAR) and T cell receptor (TCR) T cell therapies. bb2121, its lead product candidate in oncology, is a CAR T cell product candidate for the treatment of multiple myeloma. It also has discovery research programs utilizing megaTALs/homing endonuclease gene editing technologies for use across its pipeline.

  Be the first to like this.
 


 

4614  2540  813  431 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BAC 25.02-0.14 
 SPY 249.44+0.05 
 AMD 13.30-0.11 
 AAPL 151.89-1.50 
 DCTH 0.057-0.023 
 ESV 5.24+0.02 
 XLF 25.43-0.03 
 VSAR 2.675-18.925 
 GE 24.87+0.12 
 EEM 45.38-0.26 
Partners & Brokers